Investor Presentation TSX: TMD | OTCQB: TITXF September 2017 - PowerPoint PPT Presentation

Investor Presentation TSX: TMD | OTCQB: TITXF September 2017

Forward Looking Statements This presentation contains "forward-looking statements" which reflect the current expectations of management of the Company's future growth, results of operations, technological development and implementation, performance and business prospects, opportunities, and illustrations and prototypes of the SPORT™ Surgical Systems. Wherever possible, words such as "may", "would", "could", "will", "anticipate", "believe", "plan", "expect", "intend", "estimate" and similar expressions have been used to identify these forward-looking statements. These statements reflect management's current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance, achievements or technological development and implementation to be materially different from any future results, performance, achievements or technological development and implementation that may be expressed or implied by such forward-looking statements, including, without limitation, those listed in the "Risk Factors" section of the Company's Annual Information Form in respect of the fiscal year ended December 31, 2016 and other information contained in the Company’s public filings (which may be viewed at www.sedar.com). Information contained in this presentation is qualified in its entirety by such public filings. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward looking statements prove incorrect, actual results, performance or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this presentation. These factors should be considered carefully and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the presentation are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements. This presentation does not constitute an offer to sell any class of securities of the Company in any jurisdiction. PG 2

Titan Medical Overview Designer and developer of the SPORT Surgical System, a versatile single incision platform that addresses an underserved segment of the multibillion-dollar* market for abdominal surgeries performed using robotic technology. Designed for improved clinical capabilities, operating room efficiency and hospital economics. *Global Medical Robotic Systems Market to Reach $17.9 billion in 2022, Market Analysis And Segment Forecasts To 2022, Grand View Research PG 3

Leadership Team Founder, President, CEO & Chairman Domain Surgical; developer, manufacturer, marketer of advanced energy surgical platform, merged with OmniGuide in 2016 David J. McNally Co-founder, President & CEO ZEVEX International (NASDAQ: ZVXI); developer, manufacturer, marketer of award-winning medical devices, acquired by MOOG in 2007 President, CEO & Director Bachelor of Science in mechanical engineering from Lafayette College, MBA from the University of Utah, co-inventor on 30+ patents 30+ years of executive experience in established and start-up companies including accounting, finance, capital markets, tax planning, compliance, IT management, Stephen Randall, CPA mergers & acquisitions and operations Chief Financial Officer Bachelor of Arts in political science from the University of Western Ontario, Commerce Degree from the University of Windsor Expert in in medical device product development including surgical robotics, author of 32 peer-reviewed papers, inventor of 30 U.S. Patents + 24 patents pending Perry Genova PhD in biomedical engineering from the University of North Carolina at Chapel Hill, Bachelor of Science in electrical engineering from the University of North Carolina at VP of R&D Charlotte 20+ years of experience leading quality and regulatory affairs teams at established and start-up U.S. companies to achieve quality systems compliance, 510(k) clearances, Curtis Jensen CE Mark approvals VP of Quality & Reg. Affairs Master of Science in applied mathematics from Johns Hopkins University, Bachelor of Science in electrical engineering from Utah State University 20+ years of advanced medical device marketing experience, including 15 years at Intuitive Surgical developing robotic surgeon network and procedural Sachin Sankholkar expertise in multiple subspecialties VP of Marketing Master of Science in biomedical engineering from Drexel University, MBA from the University of Southern California 12+ years of advanced medical device sales and management experience, including 10 years at Intuitive Surgical and Stereotaxis with IDN/GPO sales channel expertise Chris Seibert and C-level access and network VP of Business Development Bachelor of Arts from the University of Alabama, Master of Arts in human relations from the University of Oklahoma, MBA from the University of South Alabama PG 4

Evolution of Surgical Care Minimally Open Robotic Invasive Surgery Surgery Surgery - Broad application - Minimally Invasive Surgery - Further expands upon the Open Surgery benefits of MIS (“MIS”) has been a growing - Requires significant trend over the past 25 years hospital stay and - Global robotic procedures recovery time - Reduced hospitalization time have grown from 1,000 procedures in 2000 to - Risk of adverse events - Reduced risk of adverse events 753,000* in 2016 - Requires highly skilled - Technology remains surgeons expensive with procedural and operational limitations PG 5 * Source: Intuitive Surgical press release to announce preliminary fourth quarter and full year 2016 results

Today’s Robotic Surgery Environment Robotic technology was introduced to mitigate the risks of minimally invasive surgery (MIS), reduce variations in procedural efficiency, and improve consistency of patient outcomes. Benefits Challenges - Reduced Operational + Increased Dexterity - High Cost of Entry Efficiency (long setup time) + Improved Visualization (3D) - Large Physical Footprint - Low ROI for Hospitals + Improved Ergonomics - High Level of Training - Limited Procedural - Increased Cost For Each Capability Procedure PG 6

[VALUE] $12B + da Vinci Sites US Hospitals (3) Capital Revenue [VALUE] US Ambulatory Opportunity Surgery Centers (4) [VALUE] US Hospitals 10,000 New US Placement Opportunities (1,2) Placement Opportunities (1) Based on estimate of 1 system per hospital at $1.25M per system plus accessories (2) Registered US Hospitals Source: http://www.aha.org/research/rc/stat-studies/fast-facts.shtml (3) Intuitive Surgical da Vinci US Hospitals Source: http://davincisurgeonlocator.com/ PG 7 (4) Ambulatory Surgery Centers Source: http://www.ascassociation.org/advancingsurgicalcare/whatisanasc/numberofascsperstate

$3.5B $1.25B Service Annual Revenue $2.25B ~ 10,000 placement Recurring opportunities Procedure at $125K annual Revenue service revenue Revenue each (1) ~ 1.5M available procedures at Opportunity $1,500 per procedure, $225K per system per year (2) From US Hospitals for Service and Consumables (1) $125,000 of annual service revenue per system after year 1 PG 8 (2) $1,500 per procedure revenue, assuming 150 procedures per placement per year

US Available Market (%) for Select Procedures (Data as of 2015) 100% 15% 17% 1.6M 90% 80% 50% 70% 65% US Annual 60% 92% 95% 98% 50% Available 85% 83% 40% Procedure 30% 50% 20% 35% Market (1) 10% 8% 5% 2% 0% Benign Cancer Endometriosis Cholecystectomy Colorectal Partial Prostatectomy Hysterectomy Hysterectomy Resection Procedures Nephrectomy 2015 dV Adoption (%) 2015 Available Market (%) (1) da Vinci US procedure adoption data as of 2015 per Intuitive Surgical Investor Presentation PG 9

SPORT Surgical System - Versatile single port robotic surgery solution - Overcomes multi-port robotic surgery limitations - Engineered for performance, efficiency and cost-effectiveness - Provides access to underserved market segments, such as ambulatory surgery centers PG 10

Technology Differentiation Engineered for Simplicity and Efficiency � Purposeful Single Multi- Open Ergonomic Small Design Workstation Incision Articulating Display Footprint Designed from Highly ergonomic With a single A small footprint Single-use end- 3D high definition the ground up to workstation with incision made in the OR with effectors on reusable 32” display offers the improve: natural handle around the enhanced mobility multi-articulating perfect balance of umbilicus, the instrument arms result surgical immersion interface enables and ease-of-use Clinical comfortable surgical result can be in optimal and and situational leads to quicker Capabilities posture, even during near scarless deployment in economical device awareness in the OR OR Efficiency long procedures surgery multiple ORs and performance in every higher utilization procedure Hospital Economics PG 11